EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Primary Liver Cancer Trends Worldwide and in China: Analysis of GLOBOCAN 2022 Data and Disease Management Implications

Jiayan Yan, Jiayi Wang, Jian Fan, Xinyi Cui, Yuxi Zhang, Xinrong Yang, Qiang Gao, Zhenbin Ding, Zhaoyou Tang, Jia Fan, Dan G Duda, Ao Huang und 1 weitere

Portal Hypertension & Cirrhosis · 2026-03 · 5 (1) · 65-95

DOI: 10.1002/poh2.70033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Portal Hypertension & Cirrhosis, online erschienen am 27.03.2026. Verfasst von Jiayan Yan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital Fudan University; Key Laboratory of Carcino…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 234 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary liver cancer remains a significant global public health challenge, characterized by persistently high incidence and mortality. This review synthesizes current epidemiological data to analyze trends and etiological shifts, with particular emphasis on China, which bears over 40% of the global burden. Findings highlight a transition in dominant risk factors from viral hepatitis to metabolic dysfunction‐associated steatotic liver disease (MASLD), alongside persistent threats from aflatoxin exposure and lifestyle behaviors. Evidence‐based prevention strategies, including universal hepatitis B virus (HBV) vaccination, antiviral therapy expansion, aflatoxin control, and early metabolic intervention, are critical to reducing disease burden. The integration of artificial intelligence into screening and management represents a promising advancement. A multi‐faceted approach combining vaccination, surveillance, lifestyle modification, and technological innovation is essential for effective global liver cancer control.

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery and Liver Transplantation, Liver Cancer Institute, Zhongshan Hospital Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education Shanghai China.
  • Department of Nephrology, Zhongshan Hospital Fudan University Shanghai China.
  • Department of General Practice The First Affiliated Hospital of Naval Medical University, Changhai Hospital Shanghai China.
  • Steele Laboratories for Tumor Biology, Department of Radiation Oncology Massachusetts General Hospital and Harvard Medical School Boston Massachusetts USA.
  • Transplant Oncology and Therapeutics Program, Department of Surgery Houston Methodist Academic Institute Houston Texas USA.

Förderung

  • NCI NIH HHS
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • National Institutes of Health

Zitieren

APA

Yan, J., Wang, J., Fan, J., Cui, X., Zhang, Y., Yang, X., Gao, Q., Ding, Z., Tang, Z., Fan, J., Duda, D. G., Huang, A., & Zhou, J. (2026). Primary Liver Cancer Trends Worldwide and in China: Analysis of GLOBOCAN 2022 Data and Disease Management Implications. Portal Hypertension & Cirrhosis, 5(1), 65-95. https://doi.org/10.1002/poh2.70033

Vancouver

Yan J, Wang J, Fan J, Cui X, Zhang Y, Yang X, et al. Primary Liver Cancer Trends Worldwide and in China: Analysis of GLOBOCAN 2022 Data and Disease Management Implications. Portal Hypertension & Cirrhosis. 2026;5(1):65-95. doi:10.1002/poh2.70033

BibTeX
@article{Yan2026,
  author = {Yan, Jiayan and Wang, Jiayi and Fan, Jian and Cui, Xinyi and Zhang, Yuxi and Yang, Xinrong and Gao, Qiang and Ding, Zhenbin and Tang, Zhaoyou and Fan, Jia and Duda, Dan G and Huang, Ao and Zhou, Jian},
  title = {Primary Liver Cancer Trends Worldwide and in China: Analysis of GLOBOCAN 2022 Data and Disease Management Implications},
  journal = {Portal Hypertension & Cirrhosis},
  year = {2026},
  volume = {5},
  number = {1},
  pages = {65--95},
  doi = {10.1002/poh2.70033}
}
Kostenlos starten →